Streetbeat News

Stock Prices

TSVT

2seventy Bio has announced that it will not meet its original revenue guidance of $470M-$570M for 2023. The company expects that competitive dynamics will continue to negatively affect Abecma sales in Q4.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:10 pm

BCLI

Brainstorm Cell (NASDAQ:BCLI) reported Q3 earnings with an EPS of $-0.03, surpassing the estimate of $-0.14 by 78.57%. However, revenue was the same as the previous year's same quarter. Despite beating last quarter's EPS estimates, the share price fell by 6.59% the following day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 12:10 pm

GRTX

Galera Therapeutics (NASDAQ:GRTX) reported Q3 earnings with an EPS of $-0.33, beating estimates by 17.5% but with no change in revenue from the same period last year. The previous quarter's earnings miss resulted in a 10.03% share price drop the following day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 12:10 pm

TIO

Tingo Group (NASDAQ:TIO) reported Q3 earnings with an EPS of $0.04, significantly missing the estimate of $0.46. Despite this, revenue increased by $572.47 million from the previous year. The company's past earnings miss resulted in a 5.43% share price drop the following day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 12:10 pm

DPSI

DecisionPoint Systems forecasts 2023 revenue to be between $111M-$113M, anticipating a 14-16% revenue growth and a 13-17% increase in adjusted EBITDA.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:09 pm

ALYA

Alithya Group (NASDAQ:ALYA) reported a 19.88% increase in quarterly sales, reaching $118.50M compared to $98.85M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:08 pm

LASE

Laser Photonics reported a significant decrease in Q3 EPS to $(0.13) from $0.04 YoY, while sales saw a slight increase to $1.24M from $1.22M YoY.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:07 pm

WKME

WalkMe Ltd. has reported its Q4 revenue forecast to be between $67M-$68M, which is below the estimated $69.11M. Additionally, the company has revised its full-year 2023 revenue guidance to $266.1M-$267.1M, down from the previous range of $266M-$270M and below the estimated $271.97M.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:07 pm

GRTX

Galera Therapeutics (NASDAQ:GRTX) reported a Q3 EPS loss of $0.33, surpassing the consensus estimate of a $0.40 loss by 17.5%. The loss has improved from the $0.60 per share loss in the same quarter last year. The company's cash reserves of $28.4M are expected to sustain operations and capital expenditures into 2025.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:06 pm

WKHS

Workhorse Group projects its 2023 revenues to be between $10M-$15M, significantly below the consensus estimate of $63.01M.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:05 pm